Xiaowen Tang Selected Research

12S ribosomal RNA

1/2018	Contribution of the tRNAIle 4317A→G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A→G mutation.
1/2017	Noninvasive Test for Mitochondrial DNA A1555G Mutation Associated with Deafness.
11/2015	Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutation.
4/2015	[Mitochondrial tRNA(Thr)T15943C mutation may be a new position that affects the phenotypic expression of deafness associated 12s rRNA A1555G mutation].
6/2010	Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss.
1/2010	Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation.
12/2008	Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.
5/2008	Mitochondrial ND5 T12338C, tRNA(Cys) T5802C, and tRNA(Thr) G15927A variants may have a modifying role in the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in three Han Chinese pedigrees.
10/2007	The ND4 G11696A mutation may influence the phenotypic manifestation of the deafness-associated 12S rRNA A1555G mutation in a four-generation Chinese family.
10/2007	Maternally inherited aminoglycoside-induced and nonsyndromic hearing loss is associated with the 12S rRNA C1494T mutation in three Han Chinese pedigrees.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaowen Tang Research Topics

Disease

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 07/2014
16	Deafness (Deaf Mutism) 12/2019 - 04/2006
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2013
14	Hearing Loss (Hearing Impairment) 02/2017 - 04/2006
10	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 11/2014
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2008
10	Leukemia 07/2021 - 09/2008
10	Neoplasms (Cancer) 02/2021 - 09/2015
9	Infections 01/2022 - 03/2008
7	Nonsyndromic Deafness 01/2017 - 10/2007
6	Multiple Myeloma 01/2022 - 09/2015
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 08/2014
4	Hemorrhage 02/2022 - 11/2014
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 05/2008
4	Residual Neoplasm 01/2021 - 01/2018
4	Philadelphia Chromosome 01/2020 - 10/2013
3	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 11/2013
3	Body Weight (Weight, Body) 01/2017 - 11/2014
2	Cytokine Release Syndrome 02/2022 - 01/2020
2	Hematologic Diseases (Blood Diseases) 01/2022 - 03/2015
2	Acute Promyelocytic Leukemia 12/2021 - 07/2021
2	Thrombocytopenia (Thrombopenia) 12/2021 - 12/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 06/2017
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2019 - 01/2017
2	Cholestasis 12/2016 - 01/2016
2	Insulin Resistance 01/2016 - 11/2014
2	Obesity 01/2016 - 11/2014
2	Liver Diseases (Liver Disease) 01/2016 - 04/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015 - 03/2008
2	Sensorineural Hearing Loss 05/2010 - 05/2007
2	Bilateral Hearing Loss 10/2007 - 05/2007
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Coinfection 01/2022
1	Mucormycosis 01/2022
1	Fever (Fevers) 01/2022
1	Neutropenia 12/2021
1	Pain (Aches) 11/2021
1	Disseminated Intravascular Coagulation 07/2021
1	Viremia 07/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Diabetes Mellitus 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

13	Mitochondrial DNA (mtDNA)IBA 01/2021 - 04/2006
13	AminoglycosidesIBA 01/2018 - 04/2006
11	12S ribosomal RNAIBA 01/2018 - 05/2007
8	Chimeric Antigen ReceptorsIBA 02/2022 - 01/2019
8	Decitabine FDA Link 01/2021 - 11/2014
7	Ser Transfer RNAIBA 12/2019 - 04/2006
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 01/2020
4	Transfer RNA (tRNA)IBA 01/2019 - 12/2008
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2016
3	Rituximab (Mabthera)FDA Link 01/2020 - 06/2017
3	Thr Transfer RNAIBA 01/2018 - 05/2008
3	Imatinib Mesylate (Gleevec)FDA Link 07/2015 - 03/2008
2	Interleukin-6 (Interleukin 6)IBA 02/2022 - 01/2020
2	Biological ProductsIBA 02/2021 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2016
2	LuciferasesIBA 01/2020 - 04/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2017
2	Busulfan (Busulfex)FDA Link 11/2018 - 08/2014
2	Interleukin-2 (IL2)IBA 06/2017 - 09/2008
2	Bile Acids and Salts (Bile Acids)IBA 12/2016 - 01/2016
2	NucleotidesIBA 12/2016 - 06/2010
2	LipidsIBA 01/2016 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	GlobulinsIBA 12/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 12/2021
1	AnthracyclinesIBA 12/2021
1	Capsaicin (Zostrix)FDA Link 11/2021
1	Fibrinogen (Factor I)FDA Link 07/2021
1	lusianthridinIBA 02/2021
1	AntioxidantsIBA 02/2021
1	indoleIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	GlucosidasesIBA 01/2021
1	AclarubicinIBA 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020

Therapy/Procedure

27	Hematopoietic Stem Cell Transplantation 12/2021 - 03/2008
13	Therapeutics 05/2022 - 02/2014
12	Transplantation 01/2022 - 03/2008
9	Stem Cell Transplantation 01/2022 - 01/2016
7	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
4	Cell Transplantation 12/2021 - 10/2013
3	Immunotherapy 01/2021 - 06/2017
2	Induction Chemotherapy 01/2022 - 01/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 12/2017 - 11/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2016 - 04/2015
2	Oral Administration 02/2016 - 09/2015
2	Aftercare (After-Treatment) 07/2015 - 10/2013
1	Catheters 01/2022
1	Erythrocyte Transfusion 12/2021
1	MDC protocol 07/2021
1	Salvage Therapy 12/2020
1	Intraperitoneal Injections 01/2020